ReP USP - Resultado da busca

Artigo de periodico
miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps (2021)
Silveira, Mariana L. C.; Tamashiro, Edwin; Santos, Anemari R. D.; Martins, Ronaldo B.; Faria, Francesca M.; Silva, Lilian E. C. M.; Torrieri, Raul; Ruy, Patricia de C.; Silva Júnior, Wilson Araújo da; Arruda, Eurico; Anselmo-Lima, Wilma Terezinha; Valera, Fabiana Cardoso Pereira
Source: Rhinology Journal. Unidades: FMRP, SVOI
Subjects: DOENÇA CRÔNICA, MICRORNAS, PÓLIPOS NASAIS, SINUSITE, RINITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Mariana L. C. et al. miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps. Rhinology Journal, v. 59, n. 6, p. 567-576, 2021Tradução . . Disponível em: https://doi.org/10.4193/Rhin21.109. Acesso em: 05 nov. 2024.
APA
Silveira, M. L. C., Tamashiro, E., Santos, A. R. D., Martins, R. B., Faria, F. M., Silva, L. E. C. M., et al. (2021). miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps. Rhinology Journal, 59( 6), 567-576. doi:10.4193/Rhin21.109
NLM
Silveira MLC, Tamashiro E, Santos ARD, Martins RB, Faria FM, Silva LECM, Torrieri R, Ruy P de C, Silva Júnior WA da, Arruda E, Anselmo-Lima WT, Valera FCP. miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps [Internet]. Rhinology Journal. 2021 ; 59( 6): 567-576.[citado 2024 nov. 05 ] Available from: https://doi.org/10.4193/Rhin21.109
Vancouver
Silveira MLC, Tamashiro E, Santos ARD, Martins RB, Faria FM, Silva LECM, Torrieri R, Ruy P de C, Silva Júnior WA da, Arruda E, Anselmo-Lima WT, Valera FCP. miRNA-205-5p can be related to T2-polarity in chronic rhinosinusitis with nasal polyps [Internet]. Rhinology Journal. 2021 ; 59( 6): 567-576.[citado 2024 nov. 05 ] Available from: https://doi.org/10.4193/Rhin21.109
Artigo de periodico
microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma (2020)
Roberto, Gabriela Molinari; Lira, Régia Caroline ; Delsin, Lara Elis Alberici; Vieira, Gabriela Maciel ; Silva, Marcela de Oliveira; Hakime, Rodrigo Guedes; Yamashita, Mauricio Eiji de Almeida Santos; Engel, Edgard Eduard ; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga ; Annichini, María Sol Brassesco
Source: Pathology & Oncology Research. Unidades: SVOI, FMRP, FFCLRP
Subjects: OSTEOSSARCOMA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROBERTO, Gabriela Molinari et al. microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma. Pathology & Oncology Research, v. 26, n. 2, p. 877-883, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12253-019-00633-0. Acesso em: 05 nov. 2024.
APA
Roberto, G. M., Lira, R. C., Delsin, L. E. A., Vieira, G. M., Silva, M. de O., Hakime, R. G., et al. (2020). microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma. Pathology & Oncology Research, 26( 2), 877-883. doi:10.1007/s12253-019-00633-0
NLM
Roberto GM, Lira RC, Delsin LEA, Vieira GM, Silva M de O, Hakime RG, Yamashita ME de AS, Engel EE, Scrideli CA, Tone LG, Annichini MSB. microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma [Internet]. Pathology & Oncology Research. 2020 ; 26( 2): 877-883.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s12253-019-00633-0
Vancouver
Roberto GM, Lira RC, Delsin LEA, Vieira GM, Silva M de O, Hakime RG, Yamashita ME de AS, Engel EE, Scrideli CA, Tone LG, Annichini MSB. microRNA-138-5p as a worse prognosis biomarker in pediatric, adolescent, and young adult osteosarcoma [Internet]. Pathology & Oncology Research. 2020 ; 26( 2): 877-883.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s12253-019-00633-0
Artigo de periodico
Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection (2018)
Petrilli, Raquel; Eloy, Josimar de Oliveira ; Saggioro, Fabiano Pinto ; Chesca, Deise Lúcia; Souza, Marina Claro de; Dias, Marcos Vinicios Salles; Silva, Luis Lamberti Pinto da ; Lee, Robert J.; Lopez, Renata Fonseca Vianna
Source: Journal of Controlled Release. Unidades: SVOI, FMRP, FCFRP
Subjects: MODELOS ANIMAIS, CARCINOMA DE CÉLULAS ESCAMOSAS, TUMOR CARCINOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETRILLI, Raquel et al. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection. Journal of Controlled Release, v. 283, p. 151-162, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jconrel.2018.05.038. Acesso em: 05 nov. 2024.
APA
Petrilli, R., Eloy, J. de O., Saggioro, F. P., Chesca, D. L., Souza, M. C. de, Dias, M. V. S., et al. (2018). Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection. Journal of Controlled Release, 283, 151-162. doi:10.1016/j.jconrel.2018.05.038
NLM
Petrilli R, Eloy J de O, Saggioro FP, Chesca DL, Souza MC de, Dias MVS, Silva LLP da, Lee RJ, Lopez RFV. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection [Internet]. Journal of Controlled Release. 2018 ; 283 151-162.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.jconrel.2018.05.038
Vancouver
Petrilli R, Eloy J de O, Saggioro FP, Chesca DL, Souza MC de, Dias MVS, Silva LLP da, Lee RJ, Lopez RFV. Skin cancer treatment effectiveness is improved by iontophoresis of EGFR-targeted liposomes containing 5-FU compared with subcutaneous injection [Internet]. Journal of Controlled Release. 2018 ; 283 151-162.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.jconrel.2018.05.038
Artigo de periodico
Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy (2017)
Eloy, Josimar O.; Petrilli, Raquel; Chesca, Deise Lúcia; Saggioro, Fabiano Pinto; Lee, Robert J.; Marchetti, Juliana Maldonado
Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FMRP, SVOI, FCFRP
Subjects: ANTICORPOS MONOCLONAIS, NEOPLASIAS MAMÁRIAS, LIPOSSOMOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELOY, Josimar O. et al. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, v. 115, p. 159-167, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2017.02.020. Acesso em: 05 nov. 2024.
APA
Eloy, J. O., Petrilli, R., Chesca, D. L., Saggioro, F. P., Lee, R. J., & Marchetti, J. M. (2017). Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, 115, 159-167. doi:10.1016/j.ejpb.2017.02.020
NLM
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Vancouver
Eloy JO, Petrilli R, Chesca DL, Saggioro FP, Lee RJ, Marchetti JM. Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 115 159-167.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.ejpb.2017.02.020
Artigo de periodico
HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma (2016)
Bueno, Rafaela de Barros e; Ramão, Anelisa; Pinheiro, Daniel Guariz; Alves, Cleidson Padua; Kannen, Vinicius; Jungbluth, Achim A.; Araújo, Luiza Ferreira de; Muys, Bruna Rodrigues; Fonseca, Aline Simoneti; Plaça, Jessica Rodrigues; Panepucci, Rodrigo Alexandre; Neder, Luciano; Saggioro, Fabiano P.; Mamede, Rui Celso Martins; Figueiredo, David Livingstone Alves; Silva Júnior, Wilson Araújo da
Source: Tumor Biology. Unidades: FMRP, SVOI
Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, REGULAÇÃO GÊNICA, GENES HOMEOBOX
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, Rafaela de Barros e et al. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma. Tumor Biology, v. 37, n. 11, p. 15087-15096, 2016Tradução . . Disponível em: https://doi.org/10.1007/s13277-016-5356-8. Acesso em: 05 nov. 2024.
APA
Bueno, R. de B. e, Ramão, A., Pinheiro, D. G., Alves, C. P., Kannen, V., Jungbluth, A. A., et al. (2016). HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma. Tumor Biology, 37( 11), 15087-15096. doi:10.1007/s13277-016-5356-8
NLM
Bueno R de B e, Ramão A, Pinheiro DG, Alves CP, Kannen V, Jungbluth AA, Araújo LF de, Muys BR, Fonseca AS, Plaça JR, Panepucci RA, Neder L, Saggioro FP, Mamede RCM, Figueiredo DLA, Silva Júnior WA da. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma [Internet]. Tumor Biology. 2016 ; 37( 11): 15087-15096.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s13277-016-5356-8
Vancouver
Bueno R de B e, Ramão A, Pinheiro DG, Alves CP, Kannen V, Jungbluth AA, Araújo LF de, Muys BR, Fonseca AS, Plaça JR, Panepucci RA, Neder L, Saggioro FP, Mamede RCM, Figueiredo DLA, Silva Júnior WA da. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma [Internet]. Tumor Biology. 2016 ; 37( 11): 15087-15096.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1007/s13277-016-5356-8
Artigo de periodico
Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma (2016)
Sousa, Lucas O.; Sobral, Lays M.; Matsumoto, Camila S.; Saggioro, Fabiano Pinto; López, Rossana Verónica Mendoza; Panepucci, Rodrigo Alexandre; Curti, Carlos; Silva Júnior, Wilson Araújo da; Greene, Lewis Joel; Leopoldino, Andréia Machado
Source: BBA- Biochimica et Biophysica Acta. Clinical. Unidades: SVOI, FCFRP, FMRP
Subjects: LINFONODOS, CARCINOMA DE CÉLULAS ESCAMOSAS, DIAGNÓSTICO, TERAPÊUTICA MÉDICA, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Lucas O. et al. Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma. BBA- Biochimica et Biophysica Acta. Clinical, v. 6, p. 159-164, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.bbacli.2016.11.001. Acesso em: 05 nov. 2024.
APA
Sousa, L. O., Sobral, L. M., Matsumoto, C. S., Saggioro, F. P., López, R. V. M., Panepucci, R. A., et al. (2016). Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma. BBA- Biochimica et Biophysica Acta. Clinical, 6, 159-164. doi:10.1016/j.bbacli.2016.11.001
NLM
Sousa LO, Sobral LM, Matsumoto CS, Saggioro FP, López RVM, Panepucci RA, Curti C, Silva Júnior WA da, Greene LJ, Leopoldino AM. Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma [Internet]. BBA- Biochimica et Biophysica Acta. Clinical. 2016 ; 6 159-164.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.bbacli.2016.11.001
Vancouver
Sousa LO, Sobral LM, Matsumoto CS, Saggioro FP, López RVM, Panepucci RA, Curti C, Silva Júnior WA da, Greene LJ, Leopoldino AM. Lymph node or perineural invasion is associated with low mirR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma [Internet]. BBA- Biochimica et Biophysica Acta. Clinical. 2016 ; 6 159-164.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.bbacli.2016.11.001

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Indexado em

Non normalized affiliation